Navigation Links
BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
Date:9/25/2007

atory affairs, where she oversaw products moving from late-stage research and development into Phase 1 clinical testing. Before that, she served as a team leader for Avastin, Omnitarg and Rapitva in the product portfolio management department. Prior to joining Genentech, Dr. Thomas began her career in the pharmaceutical industry as a toxicologist at Syntex Research. Dr. Thomas received her Ph.D. in toxicology and her B.S. in microbiology from the University of Kentucky.

About BiPar Sciences

BiPar Sciences Inc. (http://www.biparsciences.com) is a clinical-stage biopharmaceutical company developing and commercializing a novel class of tumor-selective drugs designed to meet the significant unmet needs of cancer patients. The Company's lead product candidate is BSI-201, which is now in early-stage clinical testing for advanced malignancies. The Company will be evaluating the potential of BSI-201 in multiple cancers and expects to file investigational new drug applications on as many as two additional cancer drug candidates in early 2008.


'/>"/>
SOURCE BiPar Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Choosing Lab Quality Management Software
3. Optimizing Quality Control Data Management
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
6. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
7. Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
8. Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success
9. Monitoring Patient Glucose Levels: New Advances in software make it easier
10. New Advances in Gastric Diagnostics: Smaller is Better
11. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  Alere Inc. (NYSE: ALR ... following statement today in support of President Barack ... "As the global leader in rapid diagnostics for infectious ... strategy to address the serious threat of antibiotic resistance. ... Administration on initiatives to promote the development of rapid ...
(Date:9/19/2014)... LONDON , September 19, 2014 ... hat Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, ... abdeckt. Die interaktive PDF, verfügbar unter pharmaserialisation.com ... an dem sie jeweils in Kraft treten. ... der Serialisierung nicht länger um das "ob", sondern ...
(Date:9/19/2014)... Reductions in kidney failure obtained ... people with diabetes type 2 "Intensive treatment ... the kidneys." Australian researchers have discovered that ... leads to persistent reductions in kidney failure many years ... study has found that, five and a half years ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3
... Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John ... Watch the Video "Congratulations ... campaign trail to earn the trust and votes of the American ... the state of our economy and jobs. "There ...
... HOPKINTON, Mass., Nov. 3, 2010 ... ), a leading provider of tools and services ... announced a collaboration with Sony DADC Austria AG ... for Caliper,s next generation microfluidics products. The agreement ...
Cached Medicine Technology:PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy 2PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy 3Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions 2
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s ... its newly announced evening cocktail dresses . As ... occasion outfits are very popular among worldwide customers. Now, ... savings (up to 65 percent off). , All ... special occasion outfits for the global clients. The company ...
(Date:9/20/2014)... GA (PRWEB) September 20, 2014 David ... 20, 2014. The first poster looked at the clinical ... cardiac cycle for calculating diastolic function. In conjunction with ... end-stage renal disease and normal LVEF by echo (>50%). ... stress protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... NY (PRWEB) September 20, 2014 Ticket ... Grande concert tickets . This popular ticket exchange is ... , The 2015 schedule of tours is beginning ... have already announced their plans to hit the road, including ... Raton, Fla., announced the “Honeymoon Tour,” which will take her ...
(Date:9/20/2014)... 2014 The print component of ... of the Calgary Herald, with a circulation of ... 270,000. The digital component is distributed nationally through ... network of top news sites and partner outlets. ... visit http://www.worklifebalanceinfo.ca . , The publication features ...
(Date:9/20/2014)... The festival season is coming soon. The high-end ... luxurious cocktail dresses . A lot of sophisticated women ... launch a new promotion for its high quality clothes. Now, ... price, from 20 to 71 percent off. , The ... They are provided in many fashionable colors. Mary, the company’s ...
Breaking Medicine News(10 mins):Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2
... to see if parents supported the proposal to ban junk ... votes in support//. ,"Ofcom has argued throughout ... advertising would be "disproportionate'," said NHF deputy chief executive Jane ... to the widespread and rising concern about the damage to ...
... pregnancy may be common and those who feel low during ... ,Annette Briley and colleagues from Tommy's Baby Charity here surveyed ... online edition of Daily Mail. ,The survey found ... they felt while being pregnant. Two thirds felt even more ...
... Most expectant parents eagerly wait for the first ultrasound sight of the ... first proof that all is well and the pregnancy is on track. ... of their child until the day of the birth. However this is ... pay hundreds of pounds for a clearer picture of their baby in ...
... the activity of a fat-induced gastrointestinal hormone that promotes ... to researchers at the Texas University Medical Branch at ... Branch at Galveston (UTMB) found the anticancer property of ... and the production of an inflammatory protein that boosts ...
... Administration. has given GlaxoSmithKline PLC's anti-seizure medicine to treat ... ,According to GlaxoSmithKline, the U.K. pharmaceutical company, the ... two and older, as well as adults. ... most-commonly occurring type of generalized seizures, seen in about ...
... Man' clinical trial were given the test drug injections ... monoclonal antibody was TGN 1412 that is supposed to ... have revealed that the victims had been injected 15 ... studies. ,Scientists claim that this 'reckless' mistake ...
Cached Medicine News:Health News:Peek Before Birth 2Health News:Curcumin –New Weapon Against Colorectal Cance 2Health News:Catastrophic Elephant Man Drug Trial Victims Injected Recklessly 2
This table has adjustable height, square post and adjustable leg. Includes clamps, and standard 1" (2.5 cm) pad....
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
... This ultralight and ultra versatile model ... twist will adjust the height of ... as a single post, or double ... armrests for physician comfort and stability. ...
The DHS Basic Set is available with either self-tapping or non-self-tapping screws. Either instrument set provides complete instrumentation in one graphic case for use with the Universal Implant Set,...
Medicine Products: